According to the new industry announcement, the company recently received a Class II “Medical Device Registration Certificate” issued by the Guangdong Drug Administration. The product is an angiotensin-converting enzyme determination kit. The registration certificate is valid from August 19, 2026 to August 18, 2031. The kit is used to quantitatively measure angiotensin-converting enzyme activity in human serum or plasma in vitro, and clinically used for monitoring medication for hypertension and auxiliary diagnosis of sarcoidosis. Up to now, the company has obtained a total of 84 “medical device registration certificates” for biochemical reagents. This certification has enriched the categories of high blood pressure projects in the company's biochemical testing products, which has had a positive impact on the company's development, but it will not have a significant impact on recent production, operation and performance.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.